Clinical trial
TAXUS VI - A Randomized, Double-blind Study to Assess Paclitaxel-eluting Stents in Treatment of Longer Lesions
NCT00297804 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TAXUS VI - A Randomized, Double-blind Study to Assess Paclitaxel-eluting Stents in Treatment of Longer Lesions
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- May 31, 2002
- Completion date
- February 29, 2008
- Enrollment
- 448 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.